About

• ReZoom first received approval from the U.S. Food and Drug Administration in April 2005. A person can expect to have better vision the very day after a ReZoom Implant procedure is performed, but the implant won't reach its full potential until a week after the procedure.
  
  

Benefits

• ReZoom is a patented optic design that acts like a bifocal lens. It allows a person to not only better see things that are near him, but also focus on things far away without being dependent on mechanical movements of the muscles.
  
  

Considerations

• People may experience discomfort after the ReZoom procedure. Those who drive at night for long periods of time are not candidates for this implant. Likewise, those who have had radial keratotomy surgery or have had problems with glare will not be considered for the procedure.